0001179110-20-003225.txt : 20200306 0001179110-20-003225.hdr.sgml : 20200306 20200306160951 ACCESSION NUMBER: 0001179110-20-003225 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200305 FILED AS OF DATE: 20200306 DATE AS OF CHANGE: 20200306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOREVIC JASON N CENTRAL INDEX KEY: 0001208500 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 20694858 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 edgar.xml FORM 4 - X0306 4 2020-03-05 0 0001477449 Teladoc Health, Inc. TDOC 0001208500 GOREVIC JASON N C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 1 1 0 0 Chief Executive Officer Common Stock 2020-03-05 4 M 0 21812 A 683264 D Common Stock 2020-03-05 4 F 0 10486 132.73 D 672778 D Common Stock 2020-03-05 4 M 0 16778 A 689556 D Common Stock 2020-03-05 4 F 0 8065 132.73 D 681493 D Performance Stock Units 2020-03-05 4 M 0 21812 0.00 D Common Stock 21812 43621 D Restricted Stock Units 2020-03-05 4 M 0 16778 0.00 D Common Stock 16778 33555 D Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. On February 26, 2020, the reporting person earned 65,433 performance stock units, vesting in three annual installments beginning on March 4, 2020. On March 4, 2019, the reporting person was granted 50,333 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. /s/ Adam C. Vandervoort, attorney-in-fact 2020-03-06